Fulgent Genetics (FLGT) EBT Margin (2015 - 2026)
Fulgent Genetics (FLGT) posted EBT Margin of 34.77% for Q2 2026, up 4.79% sequentially from 36.52% in Q1 2026, and down 846.0% YoY from 4.66% in Q2 2025.
Fulgent Genetics (FLGT) EBT Margin (2015 - 2026) Analysis & Trends
Fulgent Genetics has reported EBT Margin for 12 years, with the latest figure at 34.77% in Q2 2026.
- Quarterly EBT Margin fell 846.0% year-over-year to 34.77% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 38.36% (down 1863.0% YoY) and the FY2025 annual result came in at 21.7%, down 337.0% from the prior year.
- EBT Margin rose to 34.77% in Q2 2026 per FLGT's latest filing, from 36.52% in the prior quarter.
- Over five years, EBT Margin peaked at 63.07% in Q1 2022 and troughed at 7318.5% in Q4 2025.
- A 5-year average of 429.49% and a median of 21.82% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin soared 19538 bps in 2024, then sank 730794 bps in 2025.
- Over 5 years, EBT Margin stood at 40.03% in 2022, then sank by 415 bps to 205.94% in 2023, then jumped by 95 bps to 10.56% in 2024, then slumped by 69232 bps to 7318.5% in 2025, then soared by 100 bps to 34.77% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 34.77%, 36.52%, and 7318.5% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.21% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 6.89% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.29% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 28.17% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 10.36% |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | -34.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.77% |
| Mar 31, 2026 | -36.52% |
| Dec 31, 2025 | -7,318.50% |
| Sep 30, 2025 | -8.93% |
| Jun 30, 2025 | -26.31% |
| Mar 31, 2025 | -15.96% |
| Dec 31, 2024 | -10.56% |
| Sep 30, 2024 | -25.83% |
| Jun 30, 2024 | -15.79% |
| Mar 31, 2024 | -21.98% |
| Dec 31, 2023 | -205.94% |
| Sep 30, 2023 | 8.10% |
| Jun 30, 2023 | -21.66% |
| Mar 31, 2023 | -31.81% |
| Dec 31, 2022 | -40.03% |
| Sep 30, 2022 | 1.66% |
| Jun 30, 2022 | 10.97% |
| Mar 31, 2022 | 63.07% |
| Dec 31, 2021 | 59.93% |
| Sep 30, 2021 | 70.11% |